42 Stocks Moving in Monday's Pre-Market Session

Gainers

  • Sonnet BioTherapeutics Holdings, Inc. SONN shares rose 121.7% to $5.83 in pre-market trading after the U.S. FDA issued an emergency use authorization for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
  • ADMA Biologics, Inc. ADMA shares rose 61.9% to $4.08 in pre-market trading after declining over 5% on Friday. ADMA Biologics reported downbeat Q2 results earlier during the month.
  • ThermoGenesis Holdings, Inc. THMO rose 65.7% to $6.13 in pre-market trading after gaining around 9% on Friday. ThermoGenesis released quarterly results last week.
  • VivoPower International PLC VVPR shares rose 40.5% to $3.68 in pre-market trading after the company reported better-than-expected preliminary results for FY20.
  • Liminal BioSciences Inc. LMNL rose 38.4% to $19.01 in pre-market trading after the FDA issued an emergency use authorization for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
  • T2 Biosystems, Inc. TTOO rose 35.2% to $1.96 in pre-market trading after declining around 6% on Friday. T2 Biosystems, earlier during the month, reported upbeat quarterly results.
  • Abraxas Petroleum Corporation AXAS rose 34.1% to $0.2368 in pre-market trading after Angelo, Gordon & Co. reported a 16.6% active stake in the company.
  • Kamada Ltd. KMDA rose 24.8% to $12.48 in pre-market trading after the FDA issued an emergency use authorization for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
  • Cerus Corporation CERS rose 17.8% to $8.33 in pre-market trading. Last week, New York Times reported that the FDA has placed a hold on Cerus’s blood plasma.
  • iBio, Inc. IBIO rose 16.1% to $1.99 in pre-market trading after falling over 14% on Friday.
  • Farmmi Inc FAMI rose 15.7% to $0.82 in pre-market trading after the company announced its subsidiary, Zhejiang Forest Food has received additional orders from an existing customer.
  • Party City Holdco Inc. PRTY rose 13% to $2.26 in pre-market trading after declining 11% on Friday.
  • Tiziana Life Sciences PLC TLSA shares rose 11.3% to $4.35 in pre-market trading. Tiziana Life Sciences, on Friday, announced the award of a patent on use of Milciclib in combination with tyrosine kinase inhibitors such as Sorafenib, Regorafenib and Lenvatinib for the treatment of hepatocellular carcinoma and other cancers in humans.
  • Transocean Ltd. RIG rose 10.6% to $1.25 in pre-market trading. Transocean shares dipped over 28% on Friday on bankruptcy concerns.
  • DBV Technologies S.A. DBVT rose 10.6% to $2.30 in pre-market trading after dropping more than 5% on Friday.
  • Sphere 3D Corp. ANY rose 10.3% to $3.34 in pre-market trading. Sphere 3D, earlier during the week, released Q2 results.
  • Kazia Therapeutics Limited KZIA rose 10% to $8.23 in pre-market trading after the company disclosed that the FDA has granted Orphan Drug Designation to its paxalisib for the treatment of malignant glioma, including DIPG.
  • Cree, Inc. CREE rose 10% to $66.40 in pre-market trading. Cree issued weak Q1 earnings guidance last week.
  • CHF Solutions, Inc. CHFS rose 8.6% to $0.4997 in pre-market trading after dropping 7% on Friday. CHF Solutions, last week, reported the pricing of $12.5 million offering at $0.45 per unit.
  • Catabasis Pharmaceuticals, Inc. CATB shares rose 8.3% to $8.18 in pre-market trading after surging over 12% on Friday. Catabasis Pharmaceuticals posted a Q2 loss earlier during the month.
  • Vertiv Holdings Co. VRT shares rose 6.9% to $17.00 in pre-market trading Vertiv Holdings, earlier during the month, announced commencement of 20 million share secondary common stock offering by VPE Holdings.
  • Digital Ally, Inc. DGLY rose 6.2% to $2.22 in pre-market trading. Digital Ally released Q2 results earlier during the month.
  • Rocket Companies, Inc. RKT rose 5.8% to $27.38 in pre-market trading after surging around 9% on Friday. Rocket Companies is expected to report Q2 results on September 2.
  • Ballard Power Systems Inc BLDP rose 5.1% to $17.03 in pre-market trading after Bernstein initiated coverage with an Outperform rating and announced a $22 price target.
  • AstraZeneca plc AZN rose 3.3% to $57.56 in pre-market trading following a report suggesting President Trump is considering fast-tracking the company's coronavirus vaccine before the election.


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Northern Dynasty Minerals Ltd. NAK fell 22.1% to $1.13 in pre-market trading. The US unit of Northern Dynasty denied a report, which said the Trump administration is considering blocking its Alaska mine project.
  • Yield10 Bioscience Inc YTEN shares fell 14.1% to $4.34 in pre-market trading after the company announced a common stock offering of 835,000 shares at $4.25 per share.
  • SPAR Group, Inc. SGRP shares fell 13.5% to $0.90 in pre-market trading after jumping 20% on Friday. SPAR Group, last week, named Fay DeVriese as new Chief Financial Officer.
  • Hancock Jaffe Laboratories, Inc. HJLI fell 13.1% to $0.40 in pre-market trading. Hancock Jaffe Laboratories shares climbed 64% on Friday after the company announced two additional VenoValve patients from its first-in-man clinical study in Columbia reached the one-year milestone following VenoValve surgery and chronic venous insufficiency significantly improved in both patients.
  • Naked Brand Group Limited NAKD fell 11.9% to $0.27 in pre-market trading after declining 11% on Friday. Naked Brand Group, last week, entered into a global amendment with St.George Investments amending convertible promissory note issued by the company.
  • Midatech Pharma plc MTP fell 11.3% to $2.27 in pre-market trading after surging 22% on Friday.
  • China Natural Resources, Inc. CHNR fell 10.6% to $1.10 in pre-market trading. China Natural Resources, last week, announced it will acquire the shares of Feishang Anthracite Resources Limited.
  • Fennec Pharmaceuticals Inc. FENC fell 10.5% to $5.00 in pre-market trading. Fennec Pharmaceuticals shares, earlier during the month, announced it has received a response from the FDA for PEDMARK NDA indicating identified deficiencies with the facility of the drug product manufacturer, which require resolution prior to PEDMARK approval.
  • Mohawk Group Holdings, Inc. MWK fell 10% to $7.90 in pre-market trading after reporting a proposed public offering of common stock.
  • EyePoint Pharmaceuticals, Inc. EYPT fell 9.1% to $0.6134 in pre-market trading after gaining over 17% on Friday. Eyepoint Pharmaceuticals, last week, announced it has received an upfront payment of $9.5 million after expanding its exclusive license agreements with Ocumension Therapeutics for the development and commercialization of YUTIQ and DEXYCU.
  • Vuzix Corporation VUZI fell 8.4% to $3.95 in pre-market trading. Vuzix shares climbed over 17% on Friday after Rozetta selected the company's Smart Glasses for two separate translation-centric solutions.
  • Jaguar Health, Inc. JAGX fell 8.2% to $0.4102 in pre-market trading after declining over 10% on Friday. Jaguar Health, last week, issued updates on investigator-initiated trials of crofelemer.
  • Color Star Technology Co., Ltd. HHT fell 7.7% to $0.6818 in pre-market trading. Color Star Technology, on Friday, announced a press conference for Color World APP to be held in Beijiing, China on September 2.
  • Super League Gaming, Inc. SLGG fell 7.5% to $2.08 in pre-market trading. Super League, on Friday, announced an exclusive recreational esports partnership for its upcoming new game Venture Valley.
  • AIM ImmunoTech Inc AIM fell 7.1% to $2.23 in pre-market trading. On Friday, CEO Equels Thomas K. filed a Form 4 with the SEC. The insider bought 10,730 shares at an average price of $2.33.
  • Intec Pharma Ltd. NTEC shares fell 7% to $0.2711 in pre-market trading after declining around 6% on Friday.
  • VBI Vaccines Inc. VBIV shares fell 6.6% to $3.41 in pre-market trading after dropping over 6% on Friday. VBI Vaccines, last week, signed a manufacturing deal with Therapure Biomanufacturing for coronavirus vaccine candidates.
Posted In: Premarket MoversTop GainersNewsPenny StocksPre-Market OutlookMarketsMoversTrading Ideas